European Commission mobilising €123 million from Horizon Europe for urgent research into coronavirus variants
The Commission has launched new calls that complement earlier actions to develop treatments and vaccines by organising and conducting clinical trials to advance the development of promising therapeutics and vaccines against SARS-CoV-2/COVID-19.
1 min read - 8 Apr 2021
They will support the development of large scale, COVID-19 cohorts and networks beyond Europe’s borders, forging links with European initiatives, as well as reinforcing the infrastructures needed to share data, expertise, research resources and expert services among researchers and research organisations.
The calls open on 13 April 2021 and close on 6 May 2021, and are as follows:
- HORIZON-INFRA-2021-EMERGENCY-01: FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases
- HORIZON-INFRA-2021-EMERGENCY-02: Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics
- HORIZON-HLTH-2021-CORONA-01-01: Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment
- HORIZON-HLTH-2021-CORONA-01-02: Cohorts united against COVID-19 variants of concern
These emergency calls will tackle the short to medium-term threat and simultaneously prepare for the future. They will also contribute to building the European Health Emergency Preparedness and Response Authority (HERA), which will enable the EU to anticipate and better tackle future pandemics.
If you would like to apply for these calls, please contact the National Contact Point at the HRB, Kay Duggan-Walls: e kdugganwalls@hrb.ie
t 085 886 8183
1 min read - 8 Apr 2021